New product: Ilaxten (bilastine) 10 mg orodispersible tablets

This non-sedating, long-acting histamine antagonist with selective peripheral H1 receptor antagonist affinity is licensed for use in children aged 6 to 11 years with body weight ≥20kg for symptomatic treatment of allergic rhino-conjunctivitis (seasonal,perennial) and urticaria

Source:

electronic Medicines compendium